CR-PENEM-S:(Meropenem 1gm + Sulbactam 500mg)

Product Overview

CR-PENEM-S is a powerful combination of Meropenem and Sulbactam designed for the effective treatment of various infectious diseases. Meropenem is a broad-spectrum antibiotic that works by inhibiting cell wall synthesis in bacteria, while Sulbactam serves to protect Meropenem from degradation by beta-lactamases. This dual-action not only enhances the efficacy of the treatment but also expands its applicability against resistant bacterial strains.

Manufactured by Chemsroot Pharmaceutical, CR-PENEM-S is formulated with exceptional quality standards, evidenced by the company's ISO 9001:2015 certification and WHO GMP compliance. Such certifications ensure that users are receiving a product that meets international safety and efficacy standards. The combination of these two potent agents makes CR-PENEM-S a preferred choice for healthcare professionals when addressing complex infections.

Usage and Dosage

The recommended dosage of CR-PENEM-S should be tailored to the individual patient's condition, severity of infection, and response to therapy. Typically, adult patients may receive a dosage that is adjusted based on renal function, while pediatric doses will differ according to age and weight. It is imperative that healthcare providers follow specific guidelines and monitor for any adverse effects during treatment.

Correct administration of CR-PENEM-S is vital for optimizing therapeutic outcomes. This medication is usually administered intravenously, allowing for rapid absorption and more consistent blood levels. Patients should be instructed on the proper usage to ensure maximum efficacy and minimize the risk of antimicrobial resistance.

Quality Assurance Practices

Chemsroot Pharmaceutical places significant emphasis on quality assurance, integrating rigorous testing and validation processes throughout the manufacturing of CR-PENEM-S. Each batch undergoes extensive quality checks to ensure it meets predefined specifications and regulatory standards. This commitment to quality not only safeguards patient health but also reinforces the company’s reputation as a trusted pharmaceutical manufacturer.

The production facilities adhere to Good Manufacturing Practices (GMP), ensuring that every step of the drug manufacturing process, from raw material sourcing to final product distribution, is meticulously monitored. By maintaining these high standards, Chemsroot Pharmaceutical not only enhances the reliability of CR-PENEM-S but also contributes to better health outcomes within communities it serves.